| Similar Articles |
|---|
 |
Food Processing
December 2008 |
Absorbable Acai In the first research involving people, the acai berry has proven its ability to be absorbed in the human body when consumed both as juice and pulp.   |
The Motley Fool
June 28, 2011
Eric Bleeker |
Johnson & Johnson Is Looking Abroad for Growth Where's Johnson & Johnson generating its sales? |
Food Processing
March 2008 |
Premium, indulgent, intuitively healthful Haagen-Dazs Reserve focuses on the flavor, not the health benefits, of Brazilian Acai Berry Sorbet. |
Food Processing
December 2005
David Feder |
Power to the Purple Berries have become "berry berry" popular with consumers and food processors alike, as demonstrated in these healthy, handy applications. |
AskMen.com
Abigail Ekue-Smith |
Acai Berries How healthy are acai berries? We've done the research for you: here's a breakdown of the all-important compounds these tiny super-berries contain. |
Food Processing
August 2008 |
A taste of the rainforest Tropical juice concentrate is rich in nutrients and potential |
Food Processing
June 2013
Rory Gillespie |
Food Researchers Studying The New Wave Of Superfruits Superfruits don't need to be exotic. Even domestic fruits can pack high levels of antioxidants. |
Prepared Foods
June 5, 2007
William A. Roberts, Jr. |
Act Natural Data indicate organic products are making distinct in-roads into American buying patterns. |
The Motley Fool
November 26, 2010
Brian Orelli |
Get It Together, Johnson & Johnson Another day, another recall. |
Science News
January 27, 2007
Patrick L. Barry |
Cider May Be Healthier Than Clear Apple Juice Apple juice might be a way to keep the doctor away, but a glass of cider appears to be even better. |
Food Processing
March 2006
Diane Toops |
Rising Stars: By boomers, for boomers Newman's Own Organics, Kettle Foods and Naked Juice are in sync with their customers in ways envied by mega competitors. |
Food Processing
March 2012 |
New Food and Beverage Rollout: March 2012 Simply Orange Juice puts the squeeze on cranberries and mangos... Bossa Nova launches 90-calorie Acai Superjuices... MorningStar Farms Veggie Meatballs and Veggie Dogs... |
Prepared Foods
April 2009 |
Hitting the Shelves: An Antioxidant Boost In 2008, beverages formulated with Superfruits grew tremendously, as product introductions sought to deliver high levels of antioxidants and other ingredients rich in beneficial nutrients. |
BusinessWeek
October 28, 2010
David Sax |
What's Next in Superfoods The search for the next acai berry is on. Meet pea fiber and nova bran. |
The Motley Fool
October 19, 2011
Brian Orelli |
Not the Best Quarter, but... There's little reason to worry about Johnson & Johnson. |
Food Processing
January 2007
Frances Katz |
Flavor Trends for 2007 Will acai be the next pomegranate? Is it time to develop Argentine frozen dinners? Will dark chocolate work on pizza? |
Prepared Foods
February 1, 2008
William A. Roberts, Jr. |
Article: A Survey of the Flavor Industry --- February 2008 A marketplace demanding bolder and more varied options is driving flavor formulators into new realms of innovation. They are turning to superfruits an authentically ethnic flavors, though concerns abound. |
Fast Company
November 2006
David Lidsky |
The Superfruits Are Coming Bored with blueberries? Passing on pomegranates? Marketers are pushing a new generation of exotic, good-for-you flavors. |
The Motley Fool
January 26, 2010
Brian Orelli |
Is the Best of Johnson & Johnson Behind It? Johnson & Johnson announces that its sales fell for the first time in 76 years. |
Food Processing
December 2007
David Fede |
Wellness Ingredient Trends 2008 Trends in wellness that overarching obesity, diabetes and heart disease are spreading themselves too thin. The ingredient trends within these diseases are where processors will need to focus their energies. |
Prepared Foods
August 2007 |
Hitting the Shelves Fruit drinks with an energy kick... Pre-made soy sushi wraps... Liquid iced tea concentrate... Beneficial mints... etc. |
Fast Company
November 2015
Max Chafkin |
How Failed JC Penney CEO Ron Johnson Is Redeeming Himself With Enjoy The company sells consumer electronics via the web and has its couriers, or "Experts," in Johnson's parlance, act as modern-day Maytag Men, hand-delivering the items in as little as four hours. |
Food Processing
February 2007
Mark Anthony |
Caution: Botanicals Working Botanicals -- nutraceutical ingredients from herbs, seeds, and fruits -- are increasingly interesting to the food industry, serving health-conscious consumers demanding "nutritive-value added" food items. |
Science News
August 12, 2006
Janet Raloff |
Juice May Slow Prostate Cancer Growth (with recipe) Compounds in pomegranate juice show promise in curbing the growth of prostate cancer. Recipe: Grilled Eggplant with Pomegranate Sauce |
Food Processing
February 2010
David Feder |
Wellness Foods: Healthy Beverages offer Health in a Can Consumers are guzzling antioxidants, fruits, vegetables and other good-for-you ingredients -- but formulation hurdles remain. |
The Motley Fool
May 28, 2010
Brian Orelli |
How Much Is This Going to Cost J&J? Investors need an answer from Johnson & Johnson about low-quality drugs that were recalled. Is the problem systemic, and if so, how much will it cost the company to fix the problem? |
Food Processing
June 2007 |
Super Smoothies Insatiable demand and creative expansion of the category send smoothies into the multibillion-dollar zone. |
The Motley Fool
February 24, 2011
Brian Orelli |
Abbott: 1, Johnson & Johnson: 0 -- For Now Abbott Labs got a ruling overturned yesterday that would have cost the company $1.8 billion, yet investors let shares slip down 1%. |
The Motley Fool
May 22, 2009
Brian Orelli |
J&J and Cougar: Meow or Roar? Health-care giant Johnson & Johnson is doing something that many of its investors -- Buffett included -- wouldn't do; it's buying a development-stage drugmaker that has no proven drugs. |
Fast Company
June 2002
Alison Overholt |
Mr. Patent Marvin Johnson can't seem to stop innovating. The plainspoken scientist from Phillips Petroleum has 212 patents to his name. Here are the surprising secrets of his creative success... |
The Motley Fool
July 31, 2007
Nathan Parmelee |
Break Out the Band-Aids at J&J Johnson & Johnson is making some deep cuts to change its cost structure. Shareholders haven't had much to cheer about lately here, but the potential benefits from this move could help cure some of the current softness in the business. |
The Motley Fool
July 12, 2011
Todd Wenning |
What Does Johnson & Johnson Do With Its Free Cash? Johnson & Johnson appears to be making fair use of its free cash flow, and its well-covered dividend may be attractive to income-focused investors. |
The Motley Fool
September 30, 2009
Brian Orelli |
Boston Scientific Pays Up And Johnson & Johnson reaps the rewards. |
The Motley Fool
May 26, 2010
Brian Orelli |
Is Johnson & Johnson a Buy? Let's see what it says to Congress first on safety issues. |
The Motley Fool
June 4, 2010
Brian Orelli |
Out With Drugs, in With Medical Devices Johnson & Johnson's movement in medical devices and diagnostics is headed in the right direction, but whether Johnson & Johnson is a buy depends a lot on how it handles its current drug problem. Unfortunately investors can't have one without the other. |
Sports Central
March 16, 2015
Jeff Kallman |
Alex Johnson, RIP: The Fires Within To hear the Whitey Herzog say it, Johnson -- who died February 28 at 72, after a battle with cancer -- was anything but a handful, once you played things straight with him. |
The Motley Fool
July 14, 2008
Brian Orelli |
Foolish Forecast: J&J Trudges Along In advance of earnings analysts wonder if Johnson & Johnson is a recovery story waiting to happen, or still stuck in a rut? |
The Motley Fool
September 24, 2010
Anand Chokkavelu |
10 Core Stocks for Your Portfolio: Johnson & Johnson The health care behemoth makes the list |
Food Processing
July 2006
David Feder |
The 6 top trends in food processing Anticipating and acting on trends can make or break a company. It pays to know which ones are still in the game and which are emerging. |
Food Processing
David Feder |
This One’s a Keeper The Natural Products Expo East showcased thousands of new products for health and wellness, as usual. But there were also some interesting trends worth taking note of. |
The Motley Fool
April 29, 2011
David Williamson |
Johnson & Johnson's Traumatic Purchase Johnson & Johnson agrees to purchase trauma and spine specialist Synthes. |
Prepared Foods
May 1, 2006
Marcia A. Wade |
A Parade of Flavors Bland and common flavors are being brushed under the table by a surge of interest in flavors that are foreign, fiery and fabulous. |
The Motley Fool
January 23, 2008
Brian Orelli |
A Dose of Stability From J&J Top-line growth looked great at Johnson & Johnson -- more than 16% year over year -- but when you dove a little further into the earnings, growth wasn't quite that stellar. |
The Motley Fool
February 26, 2007
Tim Beyers |
Fool on the Street: Healthy Heinz Apparently, selling health is healthy for business. But organic innovation isn't the most important factor in going global. Investors, take note. |
The Motley Fool
January 18, 2012 |
What Johnson & Johnson Does With Its Cash Over the last five years, Johnson & Johnson shares returned 14%, which drops to -3% without dividends -- not a bad boost to top off otherwise lowly share performance. |
The Motley Fool
November 28, 2008
Brian Orelli |
The FDA's Killing Bug Killers Unfortunately for Johnson & Johnson and Swiss drugmaker Basilea Pharmaceutica, the FDA appears a little reluctant to take some of the data for the drugmakers' antibiotic ceftobiprole at face value. |
The Motley Fool
September 28, 2009
Brian Orelli |
The Berkshire of Health Care Johnson & Johnson is becoming the Berkshire Hathaway of health care. In addition to its usual M.O. of bolt-on acquisitions, the health-care giant has recently taken some equity stakes in smaller drug companies. |
The Motley Fool
February 22, 2010
Brian Orelli |
So Long, See You in Arbitration After another rejection, Johnson & Johnson and Basilea call it quits. |
The Motley Fool
August 19, 2010
Brian Orelli |
Buffett Is Buying J&J. Should You? It depends on your time horizon. |
The Motley Fool
July 2, 2009
Brian Orelli |
Squeezing Blood From a Half-Dollar Johnson & Johnson is investing $1 billion in Elan in exchange for an 18.4% stake in the company. |
